PUMA Biotech (PBYI) Director Troy Wilson Sells 5,000 Shares

What Happened Troy Edward Wilson, a director of PUMA BIOTECHNOLOGY, INC. (PBYI), sold 5,000 shares on 2026-09-14 at $9.10 per share, for total proceeds of $45,500. The transaction is reported as a sale (transaction code S) and was disclosed on a Form 4 filed on 2026-09-16.

Key Details

• Transaction date and price: 2026-09-14 — 5,000 shares at $9.10 per share (total $45,500).
• Transaction type: Sale (open market or private sale as reported).
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: The sale is associated with a 10b5-1(c) trading plan adopted 2026-06-15 (prearranged trading arrangement).
• Filing timeliness: Form 4 was filed on 2026-09-16 (appears within the standard two-business-day SEC reporting window).

Context Sales by insiders are common and can be routine (e.g., part of a 10b5-1 plan or diversification). A 10b5-1 plan indicates the trade may have been pre-scheduled and should not be taken alone as a signal of management sentiment. This report documents a sale only; no option exercises, awards, or gifts were reported in this filing.